Dr. Adetokunbo A. Ladenika, MD

Dr. Ladenika practices at LewisGale Hospital Pulaski in Pulaski, Virginia, part of HCA Healthcare.

Dr. Ladenika's NPI, 1306030143, was assigned on September 5, 2007. Dr. Ladenika holds Virginia license 0116018163.

Dr. Ladenika's primary practice is LewisGale Hospital Pulaski, at 2400 Lee Highway, Pulaski, VA 24301 in Pulaski County. The practice phone is (540) 994-8100.

Dr. Ladenika's primary practice is LewisGale Hospital Pulaski in Pulaski, Virginia, part of HCA Healthcare. Dr. Ladenika is also affiliated with Southwestern Virginia Mental Health Institute. The medical group on file is Riverside Gastroenterology Specialists. Dmand AI also links Dr. Ladenika to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ladenika practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Ladenika's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Ladenika is licensed in Virginia.

CMS data shows 86 Medicare services from Dr. Ladenika across 1 procedure code in 2024, for 21 Medicare patients. Medicare paid $4,678 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 21 Medicare patients who saw Dr. Ladenika in 2024. 75% of them have alcohol and drug use disorders, and 75% have anxiety. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ladenika's median patient age at 55, with 55% women.

In 2024, Dr. Ladenika wrote 144 Medicare Part D claims for 21 patients. 88% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $1,157 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Ladenika for performance year 2024, reported as part of a group. Dr. Ladenika accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ladenika as offering telehealth.

CMS Open Payments shows 5 general payments to Dr. Ladenika from 4 drug and device companies from 2018 to 2020. Food and beverage make up the largest share, 100% of the total. Neurocrine BioSciences, Inc. paid the most, $37.